Tirzepatide and Semaglutide: Impact on OSA in Obesity Tirzepatide and Semaglutide for the Treatment of Obstructive Sleep Apnea and Obesity: A Retrospective Analysis Onur Baser 1, Yuanqing Lu 2, Shuangrui Chen 2, Erdem Baser 3 OPEN ACCESS PUBLISHED: 31 January 2025 CITATION: Baser, O., Lu, Y., et al., 2025
Some research suggests weight regain accelerates in the first three to six months
Johnson described generic semaglutide products as "complex synthetic products that are pharmaceutically equivalent to the brand name drug, but with possible differences that could impact safety and efficacy," adding that "the manufacturer must show that these differences do not affect the safety, efficacy or quality of the drug compared to the brand name drug"
Cognitive Function and Neurobiology MT-1 has also been investigated in murine models of Alzheimers disease